Metformin Plus Megestrol Acetate as a Fertility-sparing Treatment in Patients With Atypical Endometrial Hyperplasia
Status:
Recruiting
Trial end date:
2027-02-28
Target enrollment:
Participant gender:
Summary
To verify whether metformin could improve the effect of progestin as fertility-sparing
treatment in patients with atypical endometrial hyperplasia(AEH).